Pharmaceutical Drug Delivery Market Overview 2023-2028
The global pharmaceutical drug delivery market size reached US$ 1,325 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,848 Billion by 2028, exhibiting a growth rate (CAGR) of 5.5% during 2023-2028.
Pharmaceutical drug delivery refers to the process of administering therapeutic substances within the body. It encompasses several methods of administration, including oral tablets, capsules, nasal sprays, inhalers, transdermal patches, and injections. This approach enhances the effectiveness of the administered drug by regulating its release rate, timing, and targeted location within the body. By improving patient compliance and safety, the global demand for pharmaceutical drug delivery continues to grow.
Pharmaceutical Drug Delivery Market Trends and Drivers:
Currently, the market is experiencing a surge in the prevalence of chronic diseases like cancer, diabetes, respiratory ailments, and central nervous system (CNS) disorders worldwide. This trend is a significant driver for market growth. Furthermore, there is an increasing awareness about the importance of utilizing pharmaceutical drug delivery systems effectively, which is contributing to market expansion. Additionally, individuals globally are favoring personalized, convenient, and non-invasive methods of drug administration, leading to a positive impact on the market. Moreover, the growing demand for pharmaceutical drug delivery systems in homecare settings, driven by rising healthcare expenditure, is further fueling market growth. Lastly, key industry players are introducing effective medications for various immunological disorders such as lupus and osteoarthritis, which is propelling the market forward.
Global Pharmaceutical Drug Delivery Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi S.A.
The report has segmented the market on the basis of region, route of administration, application and end user.
Breakup by Route of Administration:
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Implantable Drug Delivery
- Transmucosal Drug Delivery
- Nasal Drug Delivery
Breakup by Application:
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgery Centers
- Home Care Settings
- Diagnostic Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
